Sou Hu Cai Jing·2026-01-14 00:24Core Viewpoint - The stock of Chunli Medical (688236) has shown a significant increase, closing at 26.35 yuan on January 13, 2026, with a rise of 6.59% and notable trading activity [1] Group 1: Stock Performance - On January 13, 2026, Chunli Medical's stock price increased by 6.59%, with a trading volume of 46,600 hands and a total transaction amount of 119 million yuan [1] - The stock's turnover rate was 1.62%, indicating active trading [1] - The net inflow of main funds was 11.93 million yuan, accounting for 10.05% of the total transaction amount [1] Group 2: Fund Flow Analysis - Over the past five days, the main funds showed a net inflow on January 13, while retail investors experienced a net outflow of 16.46 million yuan, representing 13.86% of the total transaction amount [2] - The net inflow of retail funds was negative on January 12, January 9, and January 8, indicating a trend of retail selling [2] Group 3: Financing and Margin Trading - On January 13, 2026, the financing buy amounted to 13.14 million yuan, with a net financing purchase of 2.33 million yuan [3] - The total margin trading balance was 40.82 million yuan, with a financing balance of 40.50 million yuan [3] Group 4: Company Financials and Industry Comparison - Chunli Medical's total market value is 10.107 billion yuan, with a net profit of 192 million yuan, showing a significant increase of 213.21% year-on-year [5] - The company's gross margin stands at 67.27%, which is higher than the industry average of 50.62% [5] - The company ranks 39th in total market value and 33rd in net profit within the medical device industry [5] Group 5: Analyst Ratings - In the last 90 days, 8 institutions have given a buy rating for Chunli Medical, with an average target price of 31.7 yuan [6]